Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease

Neutralising monoclonal antibodies for tumour necrosis factor (TNF) has been widely used to treat Crohn’s disease (CD) in clinical practice. However, differential individual response necessitates a therapeutic response assessment of anti-TNF agents in CD patients for optimizing therapeutic strategy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Min Seob, Cha, Jae Myung, Jeon, Jung Won, Yoon, Jin Young, Park, Su Bee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036297/
https://www.ncbi.nlm.nih.gov/pubmed/35466218
http://dx.doi.org/10.3390/jfb13020036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036297/
https://www.ncbi.nlm.nih.gov/pubmed/35466218
http://dx.doi.org/10.3390/jfb13020036

Ejemplares similares